Table 2.
IC50 determination of active compounds against T. vaginalis
| Compound | IC50 (μM) (G3) |
|---|---|
| 6a | 10.49 ± 1.05 |
| 6d | 25.60 ± 1.08 |
| Metronidazolea | 0.72 |
aCurrent FDA-approved treatment for T. vaginalis infections
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.